Nonmetastatic ypt0 rectal cancer after neoadjuvant treatment and total mesorectal excision: Lessons from a retrospective multicentric cohort of 383 patients
Author:
Collard Maxime K.ORCID, Rullier Eric, Panis Yves, Manceau Gilles, Benoist Stéphane, Tuech Jean-JacquesORCID, Alves Arnaud, Laforest Anais, Mege Diane, Cazelles AntoineORCID, Beyer-Berjot LauraORCID, Christou NikiORCID, Cotte Eddy, Lakkis ZaherORCID, O’Connell Lauren, Parc YannORCID, Piessen Guillaume, Lefevre Jérémie H.ORCID
Reference34 articles.
1. Evolution of surgical treatment for rectal cancer: a review;Dayal;J Gastrointest Surg,2017 2. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial;van Gijn;Lancet Oncol,2011 3. Rectal cancer: French Intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO);Gerard;Dig Liver Dis,2017 4. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data;Maas;Lancet Oncol,2010 5. Complete pathologic response after combined modality treatment for rectal cancer and long-term survival: a meta-analysis;Zorcolo;Ann Surg Oncol,2012
|
|